Document is current
Any future updates will be listed below
-
Authors
Bouhamida, Esmaa
Vadakke-Madathil, Sangeetha
Mathiyalagan, Prabhu
Ranjan, Amaresh K.
Khan, Amir
Sherman, Cherrie D.
Miller, Paul E.
Ghetti, Andre
Abi-Gerges, Najah
Chaudhry, Hina W.
-
Funding
Funding for this research was provided by:
NIH-NHLBI (NIH R01 HL150345)
NY Stem Cell Board (C029565)
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 25 September 2025
First Online: 3 November 2025
Change Date: 16 February 2026
Change Type: Update
Change Details: In this article, funding from 'the National Institutes of Health National Heart, Lung, and Blood Institute (NIH R01 HL150345)' and 'the New York Stem Cell Science (NYSTEM C029565 and C32608GG)' was omitted from the Acknowledgements section. The original article has been corrected.
Competing interests
: H.W.C. is the inventor of multiple patents regarding cyclin A2-mediated cardiac repair and caudal-related homeobox 2 cells for cardiac repair. She is in the midst of launching a new biotechnology company to advance such therapies to clinical development. Other authors declare no financial competing interests.
